Sichuan FengChun Pharmaceutical Co., Ltd.
-
Founded in:
2000-11-24 -
Country:
China -
Address:
No. 9 Yingbin Road, Nanhua Town, Zhongjiang County, Sichuan Province -
Tax NO.:
915106232053040919 -
Registered Funds:
100 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Berberine hydrochloride |
It has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria in vitro, and has a stronger inhibitory effect on hemolytic Streptococcus, Staphylococcus aureus, Vibrio cholerae, Neisseria meningitidis, Shigella, Salmonella typhi, Corynebacterium diphtheriae, etc. It also has a certain inhibitory effect on amoeba.
More
It has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria in vitro, and has a stronger inhibitory effect on hemolytic Streptococcus, Staphylococcus aureus, Vibrio cholerae, Neisseria meningitidis, Shigella, Salmonella typhi, Corynebacterium diphtheriae, etc. It also has a certain inhibitory effect on amoeba. |
100mg | 633-65-8 | 46 |
| Trimethoprim |
It mainly interferes with bacterial folate metabolism, selectively inhibits dihydrofolate reductase, and prevents nucleic acid synthesis.
More
It mainly interferes with bacterial folate metabolism, selectively inhibits dihydrofolate reductase, and prevents nucleic acid synthesis. |
50mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| BENORILATE |
This product is a neutral compound of aspirin and acetaminophen bonded by an ester bond. It has antipyretic and analgesic effects, with fewer adverse reactions than aspirin, and is easily tolerated by patients. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is absorbed in the intestine and quickly reaches an effective concentration in the blood, and is characterized by rarely causing gastrointestinal bleeding.
More
This product is a neutral compound of aspirin and acetaminophen bonded by an ester bond. It has antipyretic and analgesic effects, with fewer adverse reactions than aspirin, and is easily tolerated by patients. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is absorbed in the intestine and quickly reaches an effective concentration in the blood, and is characterized by rarely causing gastrointestinal bleeding. |
5003-48-5 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anise oil |
It can nourish the lungs and kidneys
More
It can nourish the lungs and kidneys |
8007-70-3 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isatidis Radix |
|
0 | ||
| Sucrose |
|
57-50-1 | 73 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| DanshenP.E |
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function.
More
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function. |
0 | ||
| Starch |
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function.
More
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function. |
9005-25-8 | 79 | |
| Talc |
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function.
More
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function. |
14807-96-6 | 27 | |
| Magnesium stearate |
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function.
More
1. Dilate coronary arteries, increase coronary flow, and improve heart function. 2. Dilate peripheral blood vessels and improve microcirculation. 3. Anticoagulation, promote fibrinolysis, inhibit platelet aggregation, and inhibit thrombosis. 4. Improve the body's ability to tolerate hypoxia. 5. Promote tissue repair. 6. Regulate the central nervous system. 7. Enhance the body's immune function. |
557-04-0 | 61 |